Explore Judge Katsas Circuit Judge's 1 rulings on new drug application nda and supplemental nda snda requirements. AI-powered summaries and legal analysis.
D.C. Circuit Reverses FDA's Rejection of Vanda's Hetlioz sNDA for Pediatric Use
Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a mixed outcome. The D.C. Circuit reviewed the FDA's refusal to approve Vanda Pharmaceuticals' supplemental ...
CaseLawBrief tracks 1 new drug application nda and supplemental nda snda requirements cases decided by Judge Katsas Circuit Judge. The count updates as new opinions are published.
Based on tracked cases, outcomes include: Mixed: 1.
Judge Katsas Circuit Judge has decided new drug application nda and supplemental nda snda requirements cases in: cadc.